Literature DB >> 3133043

Gynaecomastia associated with captopril.

H M Markusse1, R H Meyboom.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3133043      PMCID: PMC2545690          DOI: 10.1136/bmj.296.6631.1262-c

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  3 in total

1.  Reversible gynaecomastia associated with D-penicillamine in a man with rheumatoid arthritis.

Authors:  D M Reid; A G Martynoga; G Nuki
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-16

2.  Massive breast enlargement in a patient receiving D-penicillamine for systemic sclerosis.

Authors:  L E Kahl; T A Medsger; I Klein
Journal:  J Rheumatol       Date:  1985-10       Impact factor: 4.666

3.  Captopril: 4 years of post marketing surveillance of all patients in New Zealand.

Authors:  I R Edwards; D M Coulter; D M Beasley; D MacIntosh
Journal:  Br J Clin Pharmacol       Date:  1987-05       Impact factor: 4.335

  3 in total
  4 in total

Review 1.  Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  R N Brogden; P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

Review 2.  Adverse effects of angiotensin converting enzyme (ACE) inhibitors. An update.

Authors:  R C Parish; L J Miller
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

Review 3.  Gynecomastia and hypertension.

Authors:  L Michael Prisant; Edward Chin
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-04       Impact factor: 3.738

Review 4.  Gynecomastia and drugs: a critical evaluation of the literature.

Authors:  Frank Q Nuttall; Rohit S Warrier; Mary C Gannon
Journal:  Eur J Clin Pharmacol       Date:  2015-04-02       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.